心理治疗对药物使用影响的关联数据研究
结果显示,治疗前一年患者使用抗精神病药物的几率是对照组的24.53倍;治疗后临床改善者比未参与者和未改善者更可能停用抗焦虑药,但治疗对抗抑郁药使用无影响。结论提示治疗服务、全科医生和精神科需加强协作以规划药物逐步减量。
要点
- 治疗前一年心理治疗患者使用抗精神病药物的几率是对照组的24.53倍。
- 治疗后临床改善者比未参与者和未改善者更可能停用抗焦虑药(OR=0.61)。
- 心理治疗对抗抑郁药使用未显示影响,提示需多学科协作规划减药。
核心结论
- 心理治疗患者治疗前抗精神病药物使用几率显著高于对照,治疗后临床改善与停用抗焦虑药相关,但治疗对抗抑郁药使用无影响。
- 结果提示治疗服务、全科医生和精神科之间需讨论是否加强参与和协作以规划药物逐步减量。
研究设计与样本
- 研究采用数据链接方法,以健康与护理编号为唯一标识符,链接心理治疗服务常规结局测量数据库(n=3625)与增强处方数据库数据。
主要发现
- 治疗前一年心理治疗患者使用抗精神病药物的几率是对照组的24.53倍(OR=24.53,95%CI 20.16-29.84)。
- 出院后第一年,治疗后临床改善的患者比未参与者和未改善者更可能停用抗焦虑药物(OR=0.61,95%CI 0.38-0.98)。
- 心理治疗对抗抑郁药使用没有影响。
临床怎么用
- 临床中应关注心理治疗患者基线抗精神病药物使用率高的情况,并在治疗前后评估药物使用变化。
- 对于治疗后临床改善的患者,可考虑与全科医生和精神科协作规划抗焦虑药物的逐步减量。
- 心理治疗对抗抑郁药使用无影响,提示需针对抗抑郁药使用另行制定管理策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The psychological therapies service (PTS) in the Northern Health and Social Care Trust, in Northern Ireland, provides therapies to adults with moderate or severe mental health difficulties. Psychometric outcomes data are routinely collected to assess if a patient demonstrates significant improvement in their main presenting problem area following therapy. The wider impact of therapy is not fully measured in the outcomes database as this would be disproportionately burdensome for both patient and therapist. The present study, to our knowledge, is the first to use data linkage to link patient therapy outcomes data with prescriptions data. AIMS: To widen our understanding of patient medication use before and after therapy. METHOD: Using Health and Care Number as a unique identifier, the Psychological Therapies Service - Routine Outcome Measurement Database (n = 3625) and data from 72 500 controls were linked with data from the Enhanced Prescribing Database (EPD). The EPD data were sourced from the Honest Broker Service. RESULTS: Key findings from the study were: (a) the odds of PTS clients using antipsychotics in the year before therapy were 25 times greater compared with controls (odds ratio (OR) = 24.53, 95% CI 20.16-29.84); (b) in the 1st year post discharge, PTS clients who clinically improved post therapy discharge were more likely than 'non-engagers' and 'non-improvers' to come off antianxiety medication (OR = 0.61, 95%, CI 0.38-0.98); and (c) therapy did not have an impact on antidepressant use. CONCLUSIONS: The results highlight the need for discussion between therapy services, GPs and psychiatry about whether more engagement and collaboration is needed to plan phased reduction in medication.
引用
- Jordan JA, Elliott A, Mongan D, et al. Measuring the impact of therapy on medication use: data-linkage study. Br J Psychiatry. 2024. PMID: 37850426. doi:10.1192/bjp.2023.130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。